Skip to main content
Top
Published in: Diabetology & Metabolic Syndrome 1/2014

Open Access 01-12-2014 | Research

N-terminal pro-B-type natriuretic peptide level inversely associates with metabolic syndrome in elderly persons

Authors: Ji-Hung Wang, Chung-Jen Lee, Jen-Che Hsieh, Yu-Chih Chen, Bang-Gee Hsu

Published in: Diabetology & Metabolic Syndrome | Issue 1/2014

Login to get access

Abstract

Aims

Serum N-terminal pro-B-type natriuretic peptide (NT-proBNP) was lower in the general population with metabolic syndrome (MetS). The aim of this study was to evaluate the relationship between MetS and fasting serum NT-proBNP concentration in elderly persons.

Methods

Fasting blood samples were obtained from 84 elderly volunteers aged 65 years or older. MetS and its components were defined using diagnostic criteria from the International Diabetes Federation.

Results

Thirty-eight elderly persons (45.2%) had MetS. Fasting NT-proBNP level was negatively correlated with MetS among elderly patients (p = 0.001). Univariate linear regression analysis showed that age (r = 0.338; p = 0.002) was positively correlated with fasting serum log-NT-proBNP levels, while height (r = -0.253; p = 0.020), body weight (r = -0.238; p = 0.029), waist circumference (r = -0.270; p = 0.013), body fat mass (r = -0.356; p = 0.002) and triglyceride (r = -0.291; p = 0.007) were negatively correlated with fasting serum log-NT-proBNP levels among the elderly persons. Multivariate forward stepwise linear regression analysis of the significant variables showed that age (R 2 change = 0.114, p = 0.011), triglyceride (R 2 change = 0.118, p < 0.001), body fat mass (R 2 change = 0.084, p < 0.001), and height (R 2 change = 0.101, p < 0.001) were the independent predictor of fasting serum log-NT-proBNP levels in elderly persons.

Conclusions

NT-proBNP level is significantly reduced in elderly persons affected by MetS, and is significantly positively related to age, while negatively related to triglyceride, body fat mass, height in these subjects.
Appendix
Available only for authorised users
Literature
2.
go back to reference Clerico A, Recchia FA, Passino C, Emdin M: Cardiac endocrine function is an essential component of the homeostatic regulation network: physiological and clinical implications. Am J Physiol Heart Circ Physiol. 2006, 290: H17-H29.CrossRefPubMed Clerico A, Recchia FA, Passino C, Emdin M: Cardiac endocrine function is an essential component of the homeostatic regulation network: physiological and clinical implications. Am J Physiol Heart Circ Physiol. 2006, 290: H17-H29.CrossRefPubMed
3.
go back to reference Gopal DJ, Iqbal MN, Maisel A: Updating the role of natriuretic peptide levels in cardiovascular disease. Postgrad Med. 2011, 123: 102-113. 10.3810/pgm.2011.11.2500.CrossRefPubMed Gopal DJ, Iqbal MN, Maisel A: Updating the role of natriuretic peptide levels in cardiovascular disease. Postgrad Med. 2011, 123: 102-113. 10.3810/pgm.2011.11.2500.CrossRefPubMed
4.
go back to reference Sarzani R, Salvi F, Dessì-Fulgheri P, Rappelli A: Renin-angiotensin system, natriuretic peptides, obesity, metabolic syndrome, and hypertension: an integrated view in humans. J Hypertens. 2008, 26: 831-843. 10.1097/HJH.0b013e3282f624a0.CrossRefPubMed Sarzani R, Salvi F, Dessì-Fulgheri P, Rappelli A: Renin-angiotensin system, natriuretic peptides, obesity, metabolic syndrome, and hypertension: an integrated view in humans. J Hypertens. 2008, 26: 831-843. 10.1097/HJH.0b013e3282f624a0.CrossRefPubMed
5.
go back to reference Beleigoli AM, Diniz MF, Ribeiro AL: Natriuretic peptides: linking heart and adipose tissue in obesity and related conditions: a systematic review. Obes Rev. 2009, 10: 617-626. 10.1111/j.1467-789X.2009.00624.x.CrossRefPubMed Beleigoli AM, Diniz MF, Ribeiro AL: Natriuretic peptides: linking heart and adipose tissue in obesity and related conditions: a systematic review. Obes Rev. 2009, 10: 617-626. 10.1111/j.1467-789X.2009.00624.x.CrossRefPubMed
6.
go back to reference Olsen MH, Hansen TW, Christensen MK, Gustafsson F, Rasmussen S, Wachtell K, et al: N-terminal pro brain natriuretic peptide is inversely related to metabolic cardiovascular risk factors and the metabolic syndrome. Hypertension. 2005, 46: 660-666. 10.1161/01.HYP.0000179575.13739.72.CrossRefPubMed Olsen MH, Hansen TW, Christensen MK, Gustafsson F, Rasmussen S, Wachtell K, et al: N-terminal pro brain natriuretic peptide is inversely related to metabolic cardiovascular risk factors and the metabolic syndrome. Hypertension. 2005, 46: 660-666. 10.1161/01.HYP.0000179575.13739.72.CrossRefPubMed
7.
go back to reference Bao Y, Shang X, Zhou L, Hu R, Li Y, Ding W: Relationship between N-terminal pro-B-type natriuretic peptide levels and metabolic syndrome. Arch Med Sci. 2011, 7: 247-256.PubMedCentralCrossRefPubMed Bao Y, Shang X, Zhou L, Hu R, Li Y, Ding W: Relationship between N-terminal pro-B-type natriuretic peptide levels and metabolic syndrome. Arch Med Sci. 2011, 7: 247-256.PubMedCentralCrossRefPubMed
8.
go back to reference Sepe A, Tchkonia T, Thomou T, Zamboni M, Kirkland JL: Aging and regional differences in fat cell progenitors - a mini-review. Gerontology. 2011, 57: 66-75. 10.1159/000279755.CrossRefPubMed Sepe A, Tchkonia T, Thomou T, Zamboni M, Kirkland JL: Aging and regional differences in fat cell progenitors - a mini-review. Gerontology. 2011, 57: 66-75. 10.1159/000279755.CrossRefPubMed
9.
go back to reference Sun DL, Wang JH, Jiang B, Li LS, Li LS, Wu L, et al: Metabolic syndrome vs. its components for prediction of cardiovascular mortality: a cohort study in Chinese elderly adults. J Geriatr Cardiol. 2012, 9: 123-129. 10.3724/SP.J.1263.2012.01172.PubMedCentralCrossRefPubMed Sun DL, Wang JH, Jiang B, Li LS, Li LS, Wu L, et al: Metabolic syndrome vs. its components for prediction of cardiovascular mortality: a cohort study in Chinese elderly adults. J Geriatr Cardiol. 2012, 9: 123-129. 10.3724/SP.J.1263.2012.01172.PubMedCentralCrossRefPubMed
10.
go back to reference Hunt SA, Abraham WT, Chin MH, Feldman AM, Francis GS, Ganiats TG, et al: 2009 focused update incorporated into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: developed in collaboration with the International Society for Heart and Lung Transplantation. Circulation. 2009, 119: e391-e479.CrossRefPubMed Hunt SA, Abraham WT, Chin MH, Feldman AM, Francis GS, Ganiats TG, et al: 2009 focused update incorporated into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: developed in collaboration with the International Society for Heart and Lung Transplantation. Circulation. 2009, 119: e391-e479.CrossRefPubMed
11.
go back to reference Hsieh JC, Wang JH, Lee CJ, Chen YC, Liou HH, Hsu BG: Low serum long-acting natriuretic peptide level correlates with metabolic syndrome in hypertensive patients: a cross-sectional study. Arch Med Res. 2013, 44: 215-220. 10.1016/j.arcmed.2013.03.001.CrossRefPubMed Hsieh JC, Wang JH, Lee CJ, Chen YC, Liou HH, Hsu BG: Low serum long-acting natriuretic peptide level correlates with metabolic syndrome in hypertensive patients: a cross-sectional study. Arch Med Res. 2013, 44: 215-220. 10.1016/j.arcmed.2013.03.001.CrossRefPubMed
12.
go back to reference Wang JH, Lee CJ, Hsieh JC, Chen YC, Hsu BG: Inversely association of long-acting natriuretic peptide with metabolic syndrome in congestive heart failure patients. Diabetol Metab Syndr. 2013, 5: 19-10.1186/1758-5996-5-19.PubMedCentralCrossRefPubMed Wang JH, Lee CJ, Hsieh JC, Chen YC, Hsu BG: Inversely association of long-acting natriuretic peptide with metabolic syndrome in congestive heart failure patients. Diabetol Metab Syndr. 2013, 5: 19-10.1186/1758-5996-5-19.PubMedCentralCrossRefPubMed
13.
go back to reference Quinones MA, Waggoner AD, Reduto LA, Nelson JG, Young JB, Winters WL, et al: A new, simplified and accurate method for determining ejection fraction with two-dimensional echocardiography. Circulation. 1981, 64: 744-753. 10.1161/01.CIR.64.4.744.CrossRefPubMed Quinones MA, Waggoner AD, Reduto LA, Nelson JG, Young JB, Winters WL, et al: A new, simplified and accurate method for determining ejection fraction with two-dimensional echocardiography. Circulation. 1981, 64: 744-753. 10.1161/01.CIR.64.4.744.CrossRefPubMed
14.
go back to reference Aizawa Y, Sakata Y, Mano T, Takeda Y, Ohtani T, Tamaki S, et al: Transition from asymptomatic diastolic dysfunction to heart failure with preserved ejection fraction – roles of systolic function and ventricular distensibility. Circ J. 2011, 75: 596-602. 10.1253/circj.CJ-10-1037.CrossRefPubMed Aizawa Y, Sakata Y, Mano T, Takeda Y, Ohtani T, Tamaki S, et al: Transition from asymptomatic diastolic dysfunction to heart failure with preserved ejection fraction – roles of systolic function and ventricular distensibility. Circ J. 2011, 75: 596-602. 10.1253/circj.CJ-10-1037.CrossRefPubMed
15.
go back to reference Alberti KG, Zimmet PZ, Shaw J: Metabolic syndrome - a new world-wide definition. A consensus statement from the International Diabetes Federation. Diabet Med. 2006, 23: 469-480. 10.1111/j.1464-5491.2006.01858.x.CrossRefPubMed Alberti KG, Zimmet PZ, Shaw J: Metabolic syndrome - a new world-wide definition. A consensus statement from the International Diabetes Federation. Diabet Med. 2006, 23: 469-480. 10.1111/j.1464-5491.2006.01858.x.CrossRefPubMed
16.
go back to reference Alberti KG, Zimmet PZ: Definition, diagnosis and classification of diabetes mellitus and its complications. I. Diagnosis and classification of diabetes mellitus: provisional report of a WHO consultation. Diabet Med. 1998, 15: 539-553. 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S.CrossRefPubMed Alberti KG, Zimmet PZ: Definition, diagnosis and classification of diabetes mellitus and its complications. I. Diagnosis and classification of diabetes mellitus: provisional report of a WHO consultation. Diabet Med. 1998, 15: 539-553. 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S.CrossRefPubMed
17.
go back to reference Lakatta EG, Levy D: Arterial and cardiac aging: major shareholders in cardiovascular disease enterprises: part I: aging arteries: a “set up” for vascular disease. Circulation. 2003, 107: 139-146. 10.1161/01.CIR.0000048892.83521.58.CrossRefPubMed Lakatta EG, Levy D: Arterial and cardiac aging: major shareholders in cardiovascular disease enterprises: part I: aging arteries: a “set up” for vascular disease. Circulation. 2003, 107: 139-146. 10.1161/01.CIR.0000048892.83521.58.CrossRefPubMed
18.
go back to reference Sinclair A, Viljoen A: The metabolic syndrome in older persons. Clin Geriatr Med. 2010, 26: 261-274. 10.1016/j.cger.2010.02.011.CrossRefPubMed Sinclair A, Viljoen A: The metabolic syndrome in older persons. Clin Geriatr Med. 2010, 26: 261-274. 10.1016/j.cger.2010.02.011.CrossRefPubMed
19.
go back to reference Noale M, Maggi S, Zanoni S, Limongi F, Zambon S, Crepaldi G, ILSA working group: The metabolic syndrome, incidence of diabetes and mortality among the elderly: the Italian Longitudinal Study of Ageing. Diabetes Metab. 2012, 38: 135-141. 10.1016/j.diabet.2011.09.005.CrossRefPubMed Noale M, Maggi S, Zanoni S, Limongi F, Zambon S, Crepaldi G, ILSA working group: The metabolic syndrome, incidence of diabetes and mortality among the elderly: the Italian Longitudinal Study of Ageing. Diabetes Metab. 2012, 38: 135-141. 10.1016/j.diabet.2011.09.005.CrossRefPubMed
20.
go back to reference Ford ES, Giles WH, Dietz WH: Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. JAMA. 2002, 287: 356-359. 10.1001/jama.287.3.356.CrossRefPubMed Ford ES, Giles WH, Dietz WH: Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. JAMA. 2002, 287: 356-359. 10.1001/jama.287.3.356.CrossRefPubMed
21.
go back to reference Savoia C, Volpe M, Alonzo A, Rossi C, Rubattu S: Natriuretic peptides and cardiovascular damage in the metabolic syndrome: molecular mechanisms and clinical implications. Clin Sci. 2009, 118: 231-240. 10.1042/CS20090204.CrossRefPubMed Savoia C, Volpe M, Alonzo A, Rossi C, Rubattu S: Natriuretic peptides and cardiovascular damage in the metabolic syndrome: molecular mechanisms and clinical implications. Clin Sci. 2009, 118: 231-240. 10.1042/CS20090204.CrossRefPubMed
22.
go back to reference Miyashita K, Itoh H, Tsujimoto H, Tamura N, Fukunaga Y, Sone M, et al: Natriuretic peptides/cGMP/cGMP-dependent protein kinase cascades promote muscle mitochondrial biogenesis and prevent obesity. Diabetes. 2009, 58: 2880-2892. 10.2337/db09-0393.PubMedCentralCrossRefPubMed Miyashita K, Itoh H, Tsujimoto H, Tamura N, Fukunaga Y, Sone M, et al: Natriuretic peptides/cGMP/cGMP-dependent protein kinase cascades promote muscle mitochondrial biogenesis and prevent obesity. Diabetes. 2009, 58: 2880-2892. 10.2337/db09-0393.PubMedCentralCrossRefPubMed
23.
go back to reference Sezen Y, Baş M, Demirbag R, Yildiz A, Celik H, Aksoy S: N-terminal pro-brain natriuretic peptide in cases with metabolic syndrome and its relationship with components of metabolic syndrome and left ventricular mass index. Clin Biochem. 2009, 42: 1500-1503. 10.1016/j.clinbiochem.2009.07.007.CrossRefPubMed Sezen Y, Baş M, Demirbag R, Yildiz A, Celik H, Aksoy S: N-terminal pro-brain natriuretic peptide in cases with metabolic syndrome and its relationship with components of metabolic syndrome and left ventricular mass index. Clin Biochem. 2009, 42: 1500-1503. 10.1016/j.clinbiochem.2009.07.007.CrossRefPubMed
24.
go back to reference Li WY, Chiu FC, Chien YF, Lin JW, Hwang JJ: Association of amino-terminal pro-brain natriuretic peptide with metabolic syndrome. Intern Med. 2011, 50: 1143-1147. 10.2169/internalmedicine.50.4765.CrossRefPubMed Li WY, Chiu FC, Chien YF, Lin JW, Hwang JJ: Association of amino-terminal pro-brain natriuretic peptide with metabolic syndrome. Intern Med. 2011, 50: 1143-1147. 10.2169/internalmedicine.50.4765.CrossRefPubMed
25.
go back to reference Nadrowski P, Chudek J, Grodzicki T, Mossakowska M, Skrzypek M, Wiecek A, et al: Plasma level of N-terminal pro brain natriuretic peptide (NT-proBNP) in elderly population in Poland - The PolSenior Study. Exp Gerontol. 2013, 48: 852-857. 10.1016/j.exger.2013.05.060.CrossRefPubMed Nadrowski P, Chudek J, Grodzicki T, Mossakowska M, Skrzypek M, Wiecek A, et al: Plasma level of N-terminal pro brain natriuretic peptide (NT-proBNP) in elderly population in Poland - The PolSenior Study. Exp Gerontol. 2013, 48: 852-857. 10.1016/j.exger.2013.05.060.CrossRefPubMed
26.
go back to reference Fradley MG, Larson MG, Cheng S, McCabe E, Coglianese E, Shah RV, et al: Reference limits for N-terminal-pro-B-type natriuretic peptide in healthy individuals (from the Framingham Heart Study). Am J Cardiol. 2011, 108: 1341-1345. 10.1016/j.amjcard.2011.06.057.PubMedCentralCrossRefPubMed Fradley MG, Larson MG, Cheng S, McCabe E, Coglianese E, Shah RV, et al: Reference limits for N-terminal-pro-B-type natriuretic peptide in healthy individuals (from the Framingham Heart Study). Am J Cardiol. 2011, 108: 1341-1345. 10.1016/j.amjcard.2011.06.057.PubMedCentralCrossRefPubMed
27.
go back to reference Wang TJ, Larson MG, Levy D, Leip EP, Benjamin EJ, Wilson PW, et al: Impact of age and sex on plasma natriuretic peptide levels in healthy adults. Am J Cardiol. 2002, 90: 254-258. 10.1016/S0002-9149(02)02464-5.CrossRefPubMed Wang TJ, Larson MG, Levy D, Leip EP, Benjamin EJ, Wilson PW, et al: Impact of age and sex on plasma natriuretic peptide levels in healthy adults. Am J Cardiol. 2002, 90: 254-258. 10.1016/S0002-9149(02)02464-5.CrossRefPubMed
28.
go back to reference Taçoy G, Açikgöz K, Kocaman SA, Ozdemir M, Cengel A: Is there a relationship between obesity, heart rate variability and inflammatory parameters in heart failure?. J Cardiovasc Med. 2010, 11: 118-124. 10.2459/JCM.0b013e328332e730.CrossRef Taçoy G, Açikgöz K, Kocaman SA, Ozdemir M, Cengel A: Is there a relationship between obesity, heart rate variability and inflammatory parameters in heart failure?. J Cardiovasc Med. 2010, 11: 118-124. 10.2459/JCM.0b013e328332e730.CrossRef
29.
go back to reference Cheng S, Fox CS, Larson MG, Massaro JM, McCabe EL, Khan AM, et al: Relation of visceral adiposity to circulating natriuretic peptides in ambulatory individuals. Am J Cardiol. 2011, 108: 979-984. 10.1016/j.amjcard.2011.05.033.PubMedCentralCrossRefPubMed Cheng S, Fox CS, Larson MG, Massaro JM, McCabe EL, Khan AM, et al: Relation of visceral adiposity to circulating natriuretic peptides in ambulatory individuals. Am J Cardiol. 2011, 108: 979-984. 10.1016/j.amjcard.2011.05.033.PubMedCentralCrossRefPubMed
30.
go back to reference Muscari A, Berzigotti A, Bianchi G, Giannoni C, Ligabue A, Magalotti D, et al: Non-cardiac determinants of NT-proBNP levels in the elderly: relevance of haematocrit and hepatic steatosis. Eur J Heart Fail. 2006, 8: 468-476. 10.1016/j.ejheart.2005.10.018.CrossRefPubMed Muscari A, Berzigotti A, Bianchi G, Giannoni C, Ligabue A, Magalotti D, et al: Non-cardiac determinants of NT-proBNP levels in the elderly: relevance of haematocrit and hepatic steatosis. Eur J Heart Fail. 2006, 8: 468-476. 10.1016/j.ejheart.2005.10.018.CrossRefPubMed
31.
go back to reference Anand IS, Fisher LD, Chiang YT, Latini R, Masson S, Maggioni AP, et al: Changes in brain natriuretic peptide and norepinephrine over time and mortality and morbidity in the Valsartan Heart Failure Trial (Val-HeFT). Circulation. 2003, 107: 1278-1283. 10.1161/01.CIR.0000054164.99881.00.CrossRefPubMed Anand IS, Fisher LD, Chiang YT, Latini R, Masson S, Maggioni AP, et al: Changes in brain natriuretic peptide and norepinephrine over time and mortality and morbidity in the Valsartan Heart Failure Trial (Val-HeFT). Circulation. 2003, 107: 1278-1283. 10.1161/01.CIR.0000054164.99881.00.CrossRefPubMed
32.
go back to reference Marinsek M, Sinkovic A: A randomized trial comparing the effect of ramipril and losartan in survivors of ST-elevation myocardial infarction. J Int Med Res. 2009, 37: 1577-1587. 10.1177/147323000903700536.CrossRefPubMed Marinsek M, Sinkovic A: A randomized trial comparing the effect of ramipril and losartan in survivors of ST-elevation myocardial infarction. J Int Med Res. 2009, 37: 1577-1587. 10.1177/147323000903700536.CrossRefPubMed
33.
go back to reference Rosenberg J, Gustafsson F, Remme WJ, Riegger GA, Hildebrandt PR: Effect of beta-blockade and ACE inhibition on B-type natriuretic peptides in stable patients with systolic heart failure. Cardiovasc Drugs Ther. 2008, 22: 305-311. 10.1007/s10557-008-6099-6.CrossRefPubMed Rosenberg J, Gustafsson F, Remme WJ, Riegger GA, Hildebrandt PR: Effect of beta-blockade and ACE inhibition on B-type natriuretic peptides in stable patients with systolic heart failure. Cardiovasc Drugs Ther. 2008, 22: 305-311. 10.1007/s10557-008-6099-6.CrossRefPubMed
34.
go back to reference Stypmann J, Schubert A, Welp H, Schulte H, Assmann G, Breithardt G, et al: Atorvastatin therapy is associated with reduced levels of N-terminal prohormone brain natriuretic peptide and improved cardiac function in patients with heart failure. Clin Cardiol. 2008, 31: 478-481. 10.1002/clc.20273.CrossRefPubMed Stypmann J, Schubert A, Welp H, Schulte H, Assmann G, Breithardt G, et al: Atorvastatin therapy is associated with reduced levels of N-terminal prohormone brain natriuretic peptide and improved cardiac function in patients with heart failure. Clin Cardiol. 2008, 31: 478-481. 10.1002/clc.20273.CrossRefPubMed
35.
go back to reference Muscari A, Bianchi G, Forti P, Giansante C, Giovagnoli M, Magalotti D, et al: A comparison of risk factors as predictors of cardiovascular and non-cardiovascular mortality in the elderly people–relevance of N-terminal pro-B-type natriuretic peptide and low systolic blood pressure. Int J Clin Pract. 2013, 67: 1182-1191. 10.1111/ijcp.12195.CrossRefPubMed Muscari A, Bianchi G, Forti P, Giansante C, Giovagnoli M, Magalotti D, et al: A comparison of risk factors as predictors of cardiovascular and non-cardiovascular mortality in the elderly people–relevance of N-terminal pro-B-type natriuretic peptide and low systolic blood pressure. Int J Clin Pract. 2013, 67: 1182-1191. 10.1111/ijcp.12195.CrossRefPubMed
36.
go back to reference Golcuk Y, Golcuk B, Velibey Y, Oray D, Atilla OD, Colak A, et al: Predictive cutoff point of admission N-terminal pro-B-type natriuretic peptide testing in the ED for prognosis of patients with acute heart failure. Am J Emerg Med. 2013, 31: 1191-1195. 10.1016/j.ajem.2013.04.038.CrossRefPubMed Golcuk Y, Golcuk B, Velibey Y, Oray D, Atilla OD, Colak A, et al: Predictive cutoff point of admission N-terminal pro-B-type natriuretic peptide testing in the ED for prognosis of patients with acute heart failure. Am J Emerg Med. 2013, 31: 1191-1195. 10.1016/j.ajem.2013.04.038.CrossRefPubMed
37.
go back to reference Tsukamoto O, Fujita M, Kato M, Yamazaki S, Asano Y, Ogai A, et al: Natriuretic peptides enhance the production of adiponectin in human adipocytes and in patients with chronic heart failure. J Am Coll Cardiol. 2009, 53: 2070-2077. 10.1016/j.jacc.2009.02.038.CrossRefPubMed Tsukamoto O, Fujita M, Kato M, Yamazaki S, Asano Y, Ogai A, et al: Natriuretic peptides enhance the production of adiponectin in human adipocytes and in patients with chronic heart failure. J Am Coll Cardiol. 2009, 53: 2070-2077. 10.1016/j.jacc.2009.02.038.CrossRefPubMed
38.
go back to reference Hung J, McQuillan BM, Thompson PL, Beilby JP: Circulating adiponectin levels associate with inflammatory markers, insulin resistance and metabolic syndrome independent of obesity. Int J Obes. 2008, 32: 772-779. 10.1038/sj.ijo.0803793.CrossRef Hung J, McQuillan BM, Thompson PL, Beilby JP: Circulating adiponectin levels associate with inflammatory markers, insulin resistance and metabolic syndrome independent of obesity. Int J Obes. 2008, 32: 772-779. 10.1038/sj.ijo.0803793.CrossRef
39.
go back to reference Sung SH, Chuang SY, Sheu WH, Lee WJ, Chou P, Chen CH: Relation of adiponectin and high-sensitivity C-reactive protein to pulse-wave velocity and N-terminal pro-B-type natriuretic peptide in the general population. Am J Cardiol. 2009, 103: 1411-1416. 10.1016/j.amjcard.2009.01.355.CrossRefPubMed Sung SH, Chuang SY, Sheu WH, Lee WJ, Chou P, Chen CH: Relation of adiponectin and high-sensitivity C-reactive protein to pulse-wave velocity and N-terminal pro-B-type natriuretic peptide in the general population. Am J Cardiol. 2009, 103: 1411-1416. 10.1016/j.amjcard.2009.01.355.CrossRefPubMed
40.
go back to reference Baldasseroni S, Mannucci E, Orso F, Di Serio C, Pratesi A, Bartoli N, et al: Adiponectin in outpatients with coronary artery disease: independent predictors and relationship with heart failure. Nutr Metab Cardiovasc Dis. 2012, 22: 292-299. 10.1016/j.numecd.2011.03.012.CrossRefPubMed Baldasseroni S, Mannucci E, Orso F, Di Serio C, Pratesi A, Bartoli N, et al: Adiponectin in outpatients with coronary artery disease: independent predictors and relationship with heart failure. Nutr Metab Cardiovasc Dis. 2012, 22: 292-299. 10.1016/j.numecd.2011.03.012.CrossRefPubMed
Metadata
Title
N-terminal pro-B-type natriuretic peptide level inversely associates with metabolic syndrome in elderly persons
Authors
Ji-Hung Wang
Chung-Jen Lee
Jen-Che Hsieh
Yu-Chih Chen
Bang-Gee Hsu
Publication date
01-12-2014
Publisher
BioMed Central
Published in
Diabetology & Metabolic Syndrome / Issue 1/2014
Electronic ISSN: 1758-5996
DOI
https://doi.org/10.1186/1758-5996-6-15

Other articles of this Issue 1/2014

Diabetology & Metabolic Syndrome 1/2014 Go to the issue